Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Chinese Patent Office
Julphar
McKesson
Medtronic
Baxter
Dow
Citi
Deloitte

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022417

« Back to Dashboard

NDA 022417 describes NORVIR, which is a drug marketed by Abbott, Abbvie, and Abbvie Inc, and is included in five NDAs. It is available from six suppliers. There are nine patents protecting this drug and two Paragraph IV challenges. Additional details are available on the NORVIR profile page.

The generic ingredient in NORVIR is ritonavir. There are twenty-one drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ritonavir profile page.
Summary for 022417
Tradename:NORVIR
Applicant:Abbvie
Ingredient:ritonavir
Patents:6
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 022417
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORVIR ritonavir TABLET;ORAL 022417 NDA AbbVie Inc. 0074-3333 N 0074-3333-30
NORVIR ritonavir TABLET;ORAL 022417 NDA A-S Medication Solutions 50090-1162 N 50090-1162-0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Feb 10, 2010TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jan 19, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Try a Free TrialPatent Expiration:May 10, 2021Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Try a Free TrialPatent Expiration:Feb 25, 2025Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 022417

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie NORVIR ritonavir TABLET;ORAL 022417-001 Feb 10, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie NORVIR ritonavir TABLET;ORAL 022417-001 Feb 10, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie NORVIR ritonavir TABLET;ORAL 022417-001 Feb 10, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie NORVIR ritonavir TABLET;ORAL 022417-001 Feb 10, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Colorcon
Daiichi Sankyo
Teva
Mallinckrodt
Chubb
Johnson and Johnson
Queensland Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.